Fifth Third Bancorp’s Insmed INSM Stock Holding History

Fifth Third Bancorp’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.98M	Buy	18,200 +17,842	+4,984%	+$2.74M	0.01%	1007
2025 Q4	$62.3K	Buy	358 +352	+5,867%	+$64.2K	﹤0.01%	1375
2025 Q3	$864	Buy	+6	New	+$735	﹤0.01%	2547
2019 Q4	–	Sell	-284	Closed	-$5K	–	2267
2019 Q3	$5K	Buy	+284	New	+$5.48K	﹤0.01%	1926

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fifth Third Bancorp's INSM Position: Q1 2026 in Review

Fifth Third Bancorp increased its Insmed (INSM) stake by 4,984% in Q1 2026, buying an estimated $2.74M and bringing the position to 18,200 shares worth $2.98M. The position accounts for 0.01% of the portfolio, ranked #1007.

Fifth Third Bancorp first reported a position in INSM in Q3 2019 and has held it in 4 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Fifth Third Bancorp held 18,200 shares of Insmed worth $2.98M as of Q1 2026.
Fifth Third Bancorp bought 17,842 Insmed shares in Q1 2026, an estimated $2.74M.
Insmed made up 0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #1007 holding.
Fifth Third Bancorp first reported a position in Insmed in Q3 2019 and has held it in 4 quarters since.
670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.